Gene · 51430
Papers1,981
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,981
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review. | Stem Cells Transl Med | 2023 | 37715961 | PubTator, text mining | PubMed |
| Similarities and Distinctions between Cortical Neural Substrates That Underlie Generation of Malevolent Creative Ideas. | eNeuro | 2023 | 37696664 | PubTator, text mining | PubMed |
| Automatic depression diagnosis through hybrid EEG and near-infrared spectroscopy features using support vector machine. | Front Neurosci | 2023 | 37694121 | PubTator, text mining | PubMed |
| Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform. | Antib Ther | 2023 | 37680350 | PubTator, text mining | PubMed |
| Identification of the ATPase alpha subunit of Trypanosoma cruzi as a potential biomarker for the diagnosis of Chagas disease. | Biomarkers | 2023 | 37667642 | PubTator, text mining | PubMed |
| Neutralization, effector function and immune imprinting of Omicron variants. | Nature | 2023 | 37648855 | PubTator, text mining | PubMed |
| Production in Bacteria and Characterization of Engineered Humanized Fab Fragment against the Nodal Protein. | Pharmaceuticals (Basel) | 2023 | 37631045 | PubTator, text mining | PubMed |
| Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment. | Int J Mol Sci | 2023 | 37629185 | PubTator, text mining | PubMed |
| Increased Actin Binding Is a Shared Molecular Consequence of Numerous SCA5 Mutations in β-III-Spectrin. | Cells | 2023 | 37626910 | PubTator, text mining | PubMed |
| IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding. | Proc Natl Acad Sci U S A | 2023 | 37603748 | PubTator, text mining | PubMed |
| A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice. | Front Immunol | 2023 | 37600814 | PubTator, text mining | PubMed |
| A new diagnostic autism spectrum disorder (DASD) strategy using ensemble diagnosis methodology based on blood tests. | Health Inf Sci Syst | 2023 | 37588694 | PubTator, text mining | PubMed |
| Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy. | J Hematol Oncol | 2023 | 37573354 | PubTator, text mining | PubMed |
| Cue to Acid-Induced Long-Range Conformational Changes in an Antibody Preceding Aggregation: The Structural Origins of the Subpeaks in Kratky Plots of Small-Angle X-ray Scattering. | Int J Mol Sci | 2023 | 37569415 | PubTator, text mining | PubMed |
| Joint attention and its linguistic representation in dialogue: embodiment revisited. | Front Psychol | 2023 | 37564303 | PubTator, text mining | PubMed |
| Interplay of heavy chain introns influences efficient transcript splicing and affects product quality of recombinant biotherapeutic antibodies from CHO cells. | MAbs | 2023 | 37555672 | PubTator, text mining | PubMed |
| Arginine cluster introduction on framework region in anti-lysozyme antibody improved association rate constant by changing conformational diversity of CDR loops. | Protein Sci | 2023 | 37550885 | PubTator, text mining | PubMed |
| Identifying novel regulatory effects for clinically relevant genes through the study of the Greek population. | BMC Genomics | 2023 | 37543566 | PubTator, text mining | PubMed |
| Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning. | Front Endocrinol (Lausanne) | 2023 | 37538797 | PubTator, text mining | PubMed |
| Cancer cell plasticity during tumor progression, metastasis and response to therapy. | Nat Cancer | 2023 | 37537300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51430/papers?page=9